Pharmacy Times

JUNE 9, 2025

The study underscores the need for improved adherence to GINA guidelines to reduce exacerbation risks and improve patient outcomes. Pharmacist-led interventions and audits of prescribing practices could enhance guideline implementation and optimize asthma management.

Pharmacy Technician 29

Pharmacy Technician Compounding Pharmacies Hospitals Pharmacy Management 29

Pharmacy Times

JULY 12, 2025

In his own community, he found chronic disease management to be a pressing need and designed a telehealth program to meet it. News release. 2018.203609 Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. May 9, 2019. December 2022.

Pharmacy Technician 26

Pharmacy Technician Independent Pharmacies Hospitals Compounding Pharmacies 26

Pharmacy Times

JUNE 16, 2025

Long-term data [are] pivotal to this, highlighting the profound impact this innovative treatment can have on atopic dermatitis well into the future,” said Baldo Scassellati Sforzolini, MD, PhD, global head of research and development at Galderma, in a news release. News release. News release. June 6, 2025. Mayo Clinic.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Biosimilars Pharmacy Management 26

Pharmacy Times

JUNE 4, 2025

Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. USP plans to continue expanding its advanced technology footprint into an additional 8,000 square foot laboratory in 2026. Learn more about USP’s supply chain solutions. Subscribe Now!

Pharmaceutical Manufacturing 26

Pharmaceutical Manufacturing Pharmacy Technician Compounding Pharmacies Compounding 26

Pharmacy Times

JUNE 19, 2025

Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. You learn what to watch for, how these therapies may be implemented, and how to prepare so we can stay up to date—for both our patients and our institutions. Subscribe Now!

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunization 26

Pharmacy Times

JUNE 18, 2025

Because Ned Said: New Technology Helps Prevent Opioid Overdose Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. J Am Pharm Assoc (2003). 2022;62(4):1407-1416.doi:10.1016/j.japh.2022.02.005 doi:10.1016/j.japh.2022.02.005 Subscribe Now!

Pharmacy Technician 26

Pharmacy Technician Immunization Immunity Diabetes 26

Pharmacy Times

JUNE 12, 2025

Consent Preferences About Us Clinical Forums Advertise Contact Us Editorial Staff Privacy Policy Terms & Conditions Do Not Sell My Information Contact Info 2 Commerce Drive Cranbury, NJ 08512 609-716-7777 © 2025 MJH Life Sciences All rights reserved. Subscribe Now!

Pharmacy Technician 45

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunization 45

Pharmacy Times

JUNE 11, 2025

Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. There is a lot of collaboration with the pharmacy on this. Once again, it is benign medicine but can have some side effects as well. Subscribe Now!

Pharmacy Technician 26

Pharmacy Technician Hospitals Specialty Pharmacies Compounding Pharmacies 26

Pharmacy Times

JUNE 25, 2025

Gabrail et al explained in the poster that new delivery platforms are being explored based on these promising results, including on-body injectors, transdermal patches, and controlled-release oral tablets. These technologies could further simplify administration and expand access to this optimized delivery strategy. Subscribe Now!

Pharmacy Technician 20

Pharmacy Technician Immunization Immunity Diabetes 20

Pharmacy Times

JUNE 13, 2025

Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Presented at: American Association of Pharmacy Technicians 2025 Annual Pharmacy Technician Convention. Denver, CO. Subscribe Now!

Pharmacy Technician 35

Pharmacy Technician Immunization Immunity Compounding Pharmacies 35

Pharmacy Times

JUNE 23, 2025

The hospital-approved protocol, created in June 2022, granted TOC pharmacists prescribing authority for guideline-directed medical therapy (GDMT), consisting of a 30-day supply of rescue and triple-therapy inhalers, at discharge for patients with AECOPD. 2023;60:469580231218625.doi:10.1177/00469580231218625 Subscribe Now!

Pharmacy Technician 26

Pharmacy Technician Hospitals Compounding Pharmacies Pharmacy Management 26

Pharmacy Times

JUNE 25, 2025

Because Ned Said: New Technology Helps Prevent Opioid Overdose Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now! Related Videos Related Content Advertisement June 25th 2025 Is Fluoride Friend or Foe?

Pharmacy Technician 20

Pharmacy Technician Medication Therapy Management (MTM) Vaccines Compounding Pharmacies 20

Pharmacy Times

JUNE 20, 2025

According to a news release, 5 times more patients in the dupilumab arm achieved sustained disease remission compared to those on placebo, defined as complete clinical remission with completion of oral corticosteroid taper by week 16 without relapse and no rescue therapy use during the 36-week treatment period. News Release.

Pharmacy Technician 33

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunization 33

Pharmacy Times

JULY 8, 2025

link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. August 8, 2024. Accessed July 8, 2025. Multiple myeloma. Cleveland Clinic. May 4, 2022. Accessed July 8, 2025. Subscribe Now!

Pharmacy Technician 29

Pharmacy Technician Immunization Immunity Compounding Pharmacies 29

Pharmacy Times

JULY 16, 2025

News release. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. JAMA Network. 2025) doi:10.1001/jamanetworkopen.2025.18261 2025.18261 2. Antimicrobial Resistance. World Health Organization. November 21, 2023. Subscribe Now!

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Hospitals Pharmacy Management 26

Pharmacy Times

JUNE 30, 2025

REMS is a useful safety system, but reevaluation over time helps inform whether a REMS is still needed to ensure that the benefits of a product outweigh its risks,” Vinay Prasad, MD, MPH, chief medical and scientific officer and director at the FDA’s Center for Biologics Evaluation and Research, said in a news release announcing the change.

Pharmacy Technician 40

Pharmacy Technician Compounding Pharmacies Immunization Immunity 40

Pharmacy Times

JUNE 9, 2025

Single-pill combination antihypertensive therapy has great potential to improve hypertension control in the United States and worldwide,” Paul Whelton, MD, show Chwan chair of Global Public Health at Tulane University, New Orleans, Louisiana, and past president of the World Hypertension League, said in a press release. 1 REFERENCES 1.

Pharmacy Technician 33

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunization 33

Pharmacy Times

JUNE 20, 2025

Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!

Diabetes 32

Diabetes Pharmacy Technician Compounding Pharmacies Pharmacy Management 32

Pharmacy Times

JUNE 11, 2025

Despite established guidelines recommending early counseling on reproductive risks and preservation options, real-world data continue to show missed opportunities for timely discussions. Fertility preservation remains a critical yet often overlooked component of comprehensive cancer care, especially among patients of reproductive age.

Pharmacy Technician 29

Pharmacy Technician Specialty Pharmacies Compounding Pharmacies Biosimilars 29

Pharmacy Times

JULY 12, 2025

2023.105496 Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subchronic oral toxicity assessment of a cannabis extract. Regulatory Toxicology and Pharmacology. 2023;144:105496. doi:10.1016/j.yrtph.2023.105496 Subscribe Now!

Pharmacy Technician 26

Pharmacy Technician Dosage Compounding Pharmacies Pharmacy Management 26

Pharmacy Times

JUNE 17, 2025

Subscribe Now!

Mail-Order Pharmacies 29

Mail-Order Pharmacies Pharmacy Technician Compounding Pharmacies Inpatient 29

Pharmacy Times

JULY 2, 2025

Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. So they have a notebook, and we really go through that every day. Subscribe Now!

Pharmacy Technician 26

Pharmacy Technician Inpatient Compounding Pharmacies Hospitals 26

Pharmacy Times

JUNE 20, 2025

link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Dabrafenib and trametinib followed by ipilimumab and nivolumab or ipilimumab and nivolumab followed by dabrafenib and trametinib in treating patients with stage III-IV BRAFV600 melanoma.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Immunization Immunity 26

Pharmacy Times

JUNE 23, 2025

Subscribe Now! Related Videos Related Content Advertisement June 23rd 2025 Transitions of Care Pharmacists Mitigate Readmission Rates for COPD Huiqiao (Melinda) Fan, BSc June 3rd 2025 S2.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Dosage Hospitals 26

Pharmacy Times

JUNE 26, 2025

News release. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Vertex’s Cell Therapy Could Be ‘Functional Cure’ for Diabetes, but Market Prospects Uncertai. June 23, 2025. Accessed June 25, 2025. Subscribe Now!

Diabetes 37

Diabetes Pharmacy Technician Compounding Pharmacies Pharmacy Management 37

Pharmacy Times

JULY 10, 2025

1 Current treatment guidelines recommend ongoing antipsychotic therapy for schizophrenia. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. The relapse-prevention trial did not raise new safety concerns. Subscribe Now!

Pharmacy Technician 20

Pharmacy Technician Hospitals Compounding Pharmacies Pharmacy Management 20

Pharmacy Times

JULY 4, 2025

link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Hadlima (adalimumab-bwwd). What is Hadlima? Accessed June 26, 2025. Hyrimoz — adalimumab-adaz. Accessed June 26, 2025. Subscribe Now!

Biosimilars 34

Biosimilars Specialty Pharmacies Pharmacy Technician Hospitals 34

Pharmacy Times

JUNE 27, 2025

Subscribe Now!

Biosimilars 20

Biosimilars Pharmacy Technician Diabetes Compounding Pharmacies 20

Pharmacy Times

JUNE 12, 2025

Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Presented at: American Association of Pharmacy Technicians 2025 Annual Pharmacy Technician Convention. Denver, CO. Subscribe Now!

Biosimilars 29

Biosimilars Pharmacy Technician Immunization Immunity 29

Pharmacy Times

JULY 16, 2025

link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. A study of zanubrutinib (BGB-3111) versus ibrutinib in participants with relapsed/​refractory chronic lymphocytic leukemia (ALPINE). Updated March 30, 2025. Accessed July 15, 2025.

Pharmacy Technician 29

Pharmacy Technician Immunization Immunity Compounding Pharmacies 29

Pharmacy Times

JUNE 9, 2025

LIMITX technology, developed by Abuse Deterrent Pharma and Acura Pharmaceuticals, controls drug release to reduce overdose risk. SHOW MORE A novel solution can strategically control the release of the drug in vivo. News release. The manufacturing process utilizes hot melt extrusion (HME) for microparticle manufacturing.

Pharmacy Technician 29

Pharmacy Technician Compounding Pharmacies Compounding Pharmacy Management 29

Pharmacy Times

JULY 15, 2025

Cytokine release syndrome was the most common adverse event, occurring in 80% of patients, with 3% experiencing grade 3 or higher. 4 The safety profile showed cytokine release syndrome (CRS) as the most common adverse event (AE) in 80% of patients, of which 3% experienced grade 3 or higher CRS. 4 At the median follow-up of 11.6

Pharmacy Technician 29

Pharmacy Technician Immunization Immunity Compounding Pharmacies 29

Pharmacy Times

JULY 1, 2025

News release. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Accessed June 30, 2025. FDA Approves VYNDAQEL® and VYNDAMAX™ for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease. May 6, 2019.

HIV Treatment and Prevention Agents 44

HIV Treatment and Prevention Agents Pharmacy Technician Insurance Coverage and Processing Specialty Pharmacies 44

Pharmacy Times

JULY 2, 2025

1 Image credit: Zerbor | stock.adobe.com “[Vancomycin], available in ready-to-infuse aseptically filled bags, exemplifies our commitment to rethinking essential medicines by making them faster to administer, easier to manage, and available when patients need them most,” Bill Larkins, president of Hikma Injectables, said in a news release.

Pharmacy Technician 29

Pharmacy Technician Hospitals Compounding Pharmacies Compounding 29

Pharmacy Times

JUNE 20, 2025

According to a news release, 5 times more patients in the dupilumab arm achieved sustained disease remission compared to those on placebo, defined as complete clinical remission with completion of oral corticosteroid taper by week 16 without relapse and no rescue therapy use during the 36-week treatment period. News Release.

Pharmacy Technician 26

Pharmacy Technician Diabetes Compounding Pharmacies Pharmacy Management 26

Pharmacy Times

JULY 9, 2025

The results suggest that venetoclax plus obinutuzumab is a guideline-recommended treatment with established efficacy; zanubrutinib may offer a more appropriate treatment option for certain patients. At 12 months, 4.8% of patients experienced serious infections, with the incidence increasing to 5.6% by 18 months. REFERENCES 1. Pharmacy Times.

Pharmacy Technician 26

Pharmacy Technician Immunization Immunity Compounding Pharmacies 26

Pharmacy Times

JULY 7, 2025

for both HCC and mCRC," Matt Schmidt, CEO of Sirtex, said in a news release. News release. News release. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. " 1 REFERENCES 1. July 7, 2025. Mayo Clinic.

Pharmacy Technician 20

Pharmacy Technician Compounding Pharmacies Diabetes Pharmacy Management 20